Following the successful launch of our new design last summer, another change at Euroimmun and IDS takes place, which makes our affiliation to Revvity, Inc. more visible.
As part of our strategic development, we are consolidating the technical systems of our three companies. This will enable us to provide an even better service thanks to streamlined processes.
This IT migration results in a change of our e-mail addresses. The process has already started in our international sites and IDS at the end of last year and will now be continued at our headquarters.
Our goal is to complete this company-wide IT migration by the end of Q3 2026. During the transition period, please refer to the relevant information in your contact person’s personal e-mail signature as well as the details provided on the Euroimmun website. The previous e-mail addresses will remain active for several months to ensure that no messages are lost.
What remains the same?
Our brand, our products and our commitment to quality and customer service will remain the same. Usual contact persons will still be available, just at a different e-mail address.
What’s new?
The technical migration resulting in the changed e-mail addresses will allow us to benefit from multiple technical and organisational synergies. In this way, we will strengthen our market position and invest in a sustainable future.
Please take a look to our contact page for further information: Contact | Euroimmun
